Innate Pharma S.A.
IPH.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €54 | €66 | €70 | €71 |
| Short-Term Investments | €6 | €14 | €22 | €22 |
| Receivables | €0 | €5 | €0 | €46 |
| Inventory | €0 | €0 | €0 | €0 |
| Other Curr. Assets | €5 | €0 | €19 | €9 |
| Total Curr. Assets | €65 | €86 | €112 | €148 |
| Property Plant & Equip (Net) | €5 | €5 | €6 | €6 |
| Goodwill | €0 | €0 | €0 | €0 |
| Intangibles | €0 | €0 | €0 | €0 |
| Long-Term Investments | €10 | €20 | €10 | €10 |
| Tax Assets | €0 | €0 | €9 | €9 |
| Other NC Assets | €13 | €1 | €15 | €11 |
| Total NC Assets | €28 | €25 | €40 | €36 |
| Other Assets | €0 | €0 | €0 | €0 |
| Total Assets | €93 | €111 | €151 | €184 |
| Liabilities | – | – | – | – |
| Payables | €5 | €16 | €9 | €9 |
| Short-Term Debt | €9 | €9 | €9 | €9 |
| Tax Payable | €0 | €0 | €0 | €7 |
| Deferred Revenue | €0 | €1 | €3 | €6 |
| Other Curr. Liab. | €16 | €7 | €18 | €9 |
| Total Curr. Liab. | €29 | €33 | €38 | €40 |
| LT Debt | €18 | €22 | €27 | €31 |
| Deferred Rev, NC | €3 | €3 | €4 | €5 |
| Deferred Tax Liab, NC | €0 | €0 | €9 | €9 |
| Other NC Liab. | €38 | €44 | €45 | €39 |
| Total NC Liab. | €58 | €69 | €84 | €93 |
| Other Liabilities | €0 | €0 | €0 | €0 |
| Cap. Leases | €1 | €0 | €1 | €1 |
| Total Liabilities | €88 | €102 | €123 | €132 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €0 | €0 | €0 |
| Common Stock | €5 | €4 | €4 | €4 |
| Retained Earnings | -€408 | -€386 | -€362 | -€337 |
| AOCI | €1 | €0 | €0 | €0 |
| Other Equity | €407 | €391 | €386 | €384 |
| Total Equity | €5 | €9 | €29 | €52 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | €93 | €111 | €151 | €184 |
| Net Debt | -€27 | -€35 | -€34 | -€31 |